If the IDO metabolic trap is found to be a feature of ME/CFS immune cells, a strong basis for the development of a specific ME/CFS diagnostic will have been discovered. This evidence concerns the gene IDO1 and myalgic encephalomeyelitis/chronic fatigue syndrome.